These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26099449)

  • 1. Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-positive bacterial infections.
    Lopez-Garcia B; Luque S; Roberts JA; Grau S
    J Infect; 2015 Nov; 71(5):604-7. PubMed ID: 26099449
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of linezolid in critically ill patients.
    Sazdanovic P; Jankovic SM; Kostic M; Dimitrijevic A; Stefanovic S
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):595-600. PubMed ID: 27020789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of linezolid in plasma and cerebrospinal fluid in patients with cerebral hemorrhage post-surgical intervention.
    Tang Y; Kong L; Wu C; Zhang X; Lu G; Wu X
    Eur J Clin Pharmacol; 2017 Jul; 73(7):919-921. PubMed ID: 28342065
    [No Abstract]   [Full Text] [Related]  

  • 4. Linezolid underexposure in a patient co-treated with venlafaxine.
    Cojutti P; Crapis M; Bassetti M; Hope W; Pea F
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1285-6. PubMed ID: 26253645
    [No Abstract]   [Full Text] [Related]  

  • 5. Decreased Linezolid Serum Concentrations in Three Critically Ill Patients: Clinical Case Studies of a Potential Drug Interaction between Linezolid and Rifampicin.
    Blassmann U; Roehr AC; Frey OR; Koeberer A; Briegel J; Huge V; Vetter-Kerkhoff C
    Pharmacology; 2016; 98(1-2):51-5. PubMed ID: 27046487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of linezolid into synovial fluid and muscle tissue after elective arthroscopy.
    Schwameis R; Syré S; Sarahrudi K; Appelt A; Marhofer D; Burau D; Kloft C; Zeitlinger M
    J Antimicrob Chemother; 2017 Oct; 72(10):2817-2822. PubMed ID: 29091212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients.
    Cojutti P; Pai MP; Pea F
    Clin Pharmacokinet; 2018 Aug; 57(8):989-1000. PubMed ID: 29080937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of linezolid treatment regimens for Gram-positive bacterial infections based on pharmacokinetic/pharmacodynamic analysis.
    Yang M; Zhang J; Chen Y; Liang X; Guo Y; Yu J; Zhu D; Zhang Y
    Future Microbiol; 2017 Jan; 12():39-50. PubMed ID: 27922745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
    Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H
    Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects.
    Eckburg PB; Ge Y; Hafkin B
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
    MacGowan AP
    J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii17-25. PubMed ID: 12730139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid more efficacious than vancomycin to eradicate infecting organism in critically ill patients with Gram-positive infections.
    Sirvent JM; Piñeiro L; de la Torre M; Motjé M; de Batlle J; Bonet A
    Rev Esp Quimioter; 2010 Mar; 23(1):27-35. PubMed ID: 20232021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia Associated with Linezolid Therapy in Solid Organ Transplant Recipients: A Retrospective Cohort Study.
    Tessier JM; Puzio T; Young A; Wolfe L; Han J; Duane TM
    Surg Infect (Larchmt); 2015 Aug; 16(4):361-7. PubMed ID: 26207396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefazolin and linezolid penetration into sternal cancellous bone during coronary artery bypass grafting.
    Andreas M; Zeitlinger M; Wisser W; Jaeger W; Maier-Salamon A; Thalhammer F; Kocher A; Hiesmayr JM; Laufer G; Hutschala D
    Eur J Cardiothorac Surg; 2015 Nov; 48(5):758-64. PubMed ID: 25527166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of high dosage of linezolid in two morbidly obese patients.
    Corcione S; Pagani N; Baietto L; Fanelli V; Urbino R; Ranieri VM; Di Perri G; D'Avolio A; De Rosa FG
    J Antimicrob Chemother; 2015 Aug; 70(8):2417-8. PubMed ID: 25957383
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged inductive effect of rifampicin on linezolid exposure.
    Gervasoni C; Simonetti FR; Resnati C; Charbe N; Clementi E; Cattaneo D
    Eur J Clin Pharmacol; 2015 May; 71(5):643-4. PubMed ID: 25778934
    [No Abstract]   [Full Text] [Related]  

  • 18. Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients.
    Kawasuji H; Tsuji Y; Ogami C; Kimoto K; Ueno A; Miyajima Y; Kawago K; Sakamaki I; Yamamoto Y
    BMC Pharmacol Toxicol; 2021 Mar; 22(1):13. PubMed ID: 33663616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of linezolid therapy in the critically ill: the effect of adjusted infusion regimens.
    Taubert M; Zander J; Frechen S; Scharf C; Frey L; Vogeser M; Fuhr U; Zoller M
    J Antimicrob Chemother; 2017 Aug; 72(8):2304-2310. PubMed ID: 28541510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy.
    Ide T; Takesue Y; Ikawa K; Morikawa N; Ueda T; Takahashi Y; Nakajima K; Takeda K; Nishi S
    Int J Antimicrob Agents; 2018 May; 51(5):745-751. PubMed ID: 29425834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.